Phase 2 Study of Atezolizumab, Bevacizumab, and Cobinetinib (taco) in Patients (pts) with PD1 Refractory Metastatic Brain Metastases (MBM)
EJC Skin Cancer（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined